Altimmune Inc (ALT)
8.01
-0.89
(-10.00%)
USD |
NASDAQ |
May 17, 16:00
8.01
0.00 (0.00%)
After-Hours: 20:00
Altimmune Stock Buybacks (Quarterly): -0.169M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.169M |
December 31, 2023 | -72.74M |
September 30, 2023 | -0.59M |
June 30, 2023 | -13.35M |
March 31, 2023 | -0.135M |
December 31, 2022 | 0.00 |
September 30, 2022 | -31.90M |
June 30, 2022 | -24.34M |
March 31, 2022 | -0.113M |
December 31, 2021 | -12.46M |
September 30, 2021 | -0.119M |
June 30, 2021 | -18.18M |
March 31, 2021 | -34.28M |
December 31, 2020 | -22.54M |
September 30, 2020 | -126.94M |
June 30, 2020 | -22.78M |
March 31, 2020 | -0.0567M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | -12.67M |
December 31, 2018 | -33.07M |
September 30, 2018 | -4.335M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | -0.0295M |
September 30, 2015 | -0.5671M |
June 30, 2015 | -0.2922M |
March 31, 2015 | -0.0843M |
December 31, 2014 | -2.801M |
September 30, 2014 | -10.07M |
June 30, 2014 | -2.556M |
March 31, 2014 | -2.719M |
December 31, 2013 | 0.05M |
September 30, 2013 | -2.258M |
June 30, 2013 | -3.757M |
March 31, 2013 | -0.0534M |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | -0.039M |
March 31, 2012 | 0.00 |
December 31, 2011 | -0.0411M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-126.94M
Minimum
Sep 2020
--
Maximum
Jun 2019
-19.03M
Average
-6.524M
Median
Stock Buybacks (Quarterly) Benchmarks
Eli Lilly and Co | 0.00 |
Amgen Inc | -- |
Pfizer Inc | -- |
Viking Therapeutics Inc | -597.12M |
GlycoMimetics Inc | 0.00 |